Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes
Monzr Al Malki(City of Hope), Ryotaro Nakamura(City Of Hope National Medical Center), Chatchada Karanes(Erasmus MC Cancer Institute), Stephen J. Forman(City Of Hope National Medical Center), Sanjeet Dadwal(City Of Hope National Medical Center), Ibrahim Aldoss(City of Hope), Guido Marcucci(City of Hope), Amandeep Salhotra(City of Hope), Haris Ali(City of Hope), Dongyun Yang(City of Hope), Ketevan Gendzekhadze(City Of Hope National Medical Center), John A. Zaia(City Of Hope National Medical Center), Thai M. Cao(City of Hope), Pablo Parker(City Of Hope National Medical Center), Auayporn Nademanee(City Of Hope National Medical Center), Don J. Diamond(City of Hope), David S. Snyder(City Of Hope National Medical Center), Sally Mokhtari(City of Hope)
Cited by 2
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k